• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

merck
Health
The cholesterol shot you couldn’t afford is now a pill
By Matthew Perrone and The Associated PressJuly 16, 2026
hegseth
Health
Only 12% of testosterone prescriptions are medically necessary — and Trump wants to make that ratio even smaller
By Matthew Perrone and The Associated PressJuly 16, 2026
pete
Politics
Pete Hegseth wants to test troops for ‘testosterone deficiency’ — literally
By Konstantin Toropin, Matthew Perrone and The Associated PressJuly 15, 2026
Meet the lone star tick: the primary U.S. source of alpha-gal syndrome, which is a life-threatening meat allergy that’s on the rise
Health
Meet the lone star tick: the primary U.S. source of alpha-gal syndrome, which is a life-threatening meat allergy that’s on the rise
By Matthew Perrone and The Associated PressJune 13, 2026
fda
Health
Why is the FDA approving kid-friendly, fruit-flavored e-cigarettes?
By Matthew Perrone and The Associated PressJune 12, 2026
fda
Banking
FDA’s tobacco center just drafted new rules to let ecigs, pouches onto market, but staffers didn’t write them
By Matthew Perrone and The Associated PressMay 23, 2026
hoeg
Health
RFK ally confirms she was fired by FDA: ‘I learned so much and leave with no regrets’
By Matthew Perrone and The Associated PressMay 16, 2026
FDA Commissioner Dr. Marty Makary announced his resignation after a rocky year
Politics
FDA Commissioner Dr. Marty Makary announced his resignation after a rocky year
By The Associated Press and Matthew PerroneMay 12, 2026
Hallucinogenics are illegal under federal law but that isn’t stopping the FDA from fast tracking 3 psychedelic drugs to treat mental health
Politics
Hallucinogenics are illegal under federal law but that isn’t stopping the FDA from fast tracking 3 psychedelic drugs to treat mental health
By Matthew Perrone and The Associated PressApril 24, 2026
Trump speeds review of psychedelics after Joe Rogan texted him about ibogaine. ‘Sounds great. Do you want FDA approval? Let’s do it’
Politics
Trump speeds review of psychedelics after Joe Rogan texted him about ibogaine. ‘Sounds great. Do you want FDA approval? Let’s do it’
By Matthew Perrone, Seung Min Kim and The Associated PressApril 18, 2026
FDA
Health
Female libido pill gets expanded approval for menopause by FDA
By Matthew Perrone and The Associated PressDecember 15, 2025
Medical Glasses
Innovation
New FDA-approved glasses can slow nearsightedness in kids
By The Associated Press and Matthew PerroneDecember 1, 2025
Jim O'Neill
Politics
The new head of the CDC has no training in medicine and once helped Peter Thiel develop man-made islands floating outside U.S. territory
By Matthew Perrone and The Associated PressAugust 29, 2025
Within a year, RFK wants to help you treat depression with psychedelics, LSD and ecstasy
Health
Within a year, RFK wants to help you treat depression with psychedelics, LSD and ecstasy
By Matthew Perrone and The Associated PressJuly 17, 2025
RFK Jr.‘s top FDA vaccine official restricts 2 COVID vaccine approvals against advice of agency scientists
Health
RFK Jr.‘s top FDA vaccine official restricts 2 COVID vaccine approvals against advice of agency scientists
By Matthew Perrone and The Associated PressJuly 3, 2025
1
  • 1
  • 2
  • 3
  • 4
  • 5
...8
Most Popular
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
AI
Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyardplaceholder alt text
By Aaron Walayat and The ConversationJuly 19, 2026
Success
Red Lobster’s 37-year-old CEO waited tables before joining the C-suite—he says it was a crash course in managing ‘difficult people and situations’placeholder alt text
By Preston ForeJuly 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.